 Business Today |
Glenmark hits 52-week high on US nod for asthma generic drug
Business Today Shares of Glenmark Pharma hit a fresh 52-week high on Monday after the company received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies . Glenmark said it would … |
View full post on asthma – Google News